COB-214

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameCOB-214
Drug Alias NameInhibitor of inflammation (Ohio University)COB-214
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsFatty Liver
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesOhio University
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesOhio University
Active IndicationsN/A
Inactive IndicationsFatty Liver

Other Information

ATC CodeN/A
Related LinksN/A